🔎 Trials Near Me

መነሻ › ፎሊኩላር ሊምፎማ › New Jersey

በNew Jersey ለፎሊኩላር ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለፎሊኩላር ሊምፎማ የሚደረጉ 15 ጥናቶች በNew Jersey ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በNew Jersey ውስጥ ያሉ ከተሞች

Official study text (English)

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Hackensack University Medical Center, Hackensack
  • Memorial Sloan Kettering Monmouth, Middletown
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07215910

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

  • Research Site, Hackensack
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06542250

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1311), Hackensack
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07634471

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Rutgers Cancer Institute of New Jersey, New Brunswick
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07101328

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  • Research Site, Hackensack
  • Research Site, New Brunswick
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06549595

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Rutgers Cancer Institute, New Brunswick
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • John Theurer Cancer Center Hackensack University Medical Center, Hackensack
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05826535

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

  • Rutgers Cancer Institute of New Jersey, New Brunswick
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT04792502

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge
  • Hackensack Meridian Health (Data collection only), Hackensack
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT05389293

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • START New Jersey, East Brunswick
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT07424833

SynKIR-310 for Relapsed/Refractory B-NHL

  • Rutgers Cancer Institute, New Brunswick
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኤፕሪ 2026 · NCT06544265

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

  • Rutgers Cancer Institute of New Jersey, New Brunswick
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ማርች 2026 · NCT04998669

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ፌብሩ 2026 · NCT07029217

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Regional Cancer Care Associates, Hackensack
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT05544019

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Brunswick
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።